CADENCE CAPITAL MANAGEMENT LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 240 filers reported holding BLUEBIRD BIO INC in Q2 2015. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q1 2017$579,000
-19.0%
6,370
-39.6%
0.04%
-23.1%
Q3 2016$715,000
-84.2%
10,550
-71.9%
0.05%
-81.2%
Q1 2015$4,536,000
-19.7%
37,559
-39.0%
0.28%
-15.8%
Q4 2014$5,650,00061,5980.33%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,335,528$40,104,0004.92%
qPULA Trading Management LP 14,344$91,0000.80%
Frazier Life Sciences Management, L.P. 1,440,757$9,120,0000.70%
Ikarian Capital, LLC 462,628$2,928,0000.58%
Birchview Capital, LP 98,000$620,0000.44%
HealthCor Management, L.P. 455,000$2,880,0000.36%
Financial Advocates Investment Management 45,071$3,538,0000.29%
PDT Partners, LLC 262,767$1,663,0000.25%
Monaco Asset Management SAM 80,000$506,0000.19%
Summit X, LLC 103,424$651,0000.19%
View complete list of BLUEBIRD BIO INC shareholders